Why is Evoq Remedies falling/rising?

As of 24-Sep, Evoq Remedies Ltd is experiencing a price increase, with its current price at 4.55, reflecting a change of 0.38 or 9.11% upward. The stock has shown strong performance in the short term, with a 1-week return of +27.09% and a 1-month return of +32.65%, significantly outperforming the Sensex, which has seen a decline of -1.18% over the same week and a modest increase of +0.50% over the month. However, despite this recent upward trend, the stock's year-to-date performance remains concerning, with a decline of -41.67%. Today's price summary indicates that the stock has outperformed its sector by 9.56%, but there is a noted decrease in investor participation, with delivery volume falling by -16.67% compared to the 5-day average. Additionally, while the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average, suggesting mixed signals regarding its long-term trend.
In the broader market context, Evoq Remedies' recent performance contrasts sharply with the benchmark, as it has gained significantly in the short term while the Sensex has declined. This divergence indicates a potential shift in investor sentiment specifically towards Evoq Remedies, possibly driven by factors not detailed in the provided data. The stock's liquidity appears adequate for trading, as it is based on 2% of the 5-day average traded value, which supports its recent price movement. However, the lack of available positive or negative dashboard text data limits a deeper understanding of the specific catalysts behind the stock's rise.